HHS Inspector General Daniel Levinson's office audited all $185 billion in drugs that were prescribed during the first 3 years of the new prescription-drug benefit program, known in government circles as Medicare Part D, and found that a narrow share—less than 1%—was ordered by doctors prohibited from prescribing between 2006 and 2008.
Auditors pinpointed several inadequate internal controls that allowed at least $15.1 million in prohibited prescriptions to be dispensed to patients, including the CMS' past practice of not allowing its prescription-drug contractors access to a central database of prohibited prescribers. Auditors also criticized the HHS contractors' use of state indentifiers in screening databases instead of unique national provider identifier numbers.
Read more at: http://tinyurl.com/7hh94hh
Source: Modern Healthcare
In part because of past shortcomings in a centralized database, the Centers for Medicare & Medicaid Services (CMS) and its contractors that administer the Medicare prescription-drug benefit have allowed more than $15 million worth of drugs to be dispensed to patients by doctors whose past criminal activity should have barred them from prescribing, according to a new report (PDF).
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More